Insider · CIK 0001516368

Lapuerta Pablo

Reports to the SEC for 1 company · THE WOODLANDS, TX

sec.gov

Transactions

Companies

Filings

CIK

0001516368

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2020-04-22	LXRXLEXICON PHARMACEUTICALS, INC.A Award	EVP and CMO	AAward	+19.9K sh	—	—	92,532
2020-04-22	LXRXLEXICON PHARMACEUTICALS, INC.F Tax Payment	EVP and CMO	FTax Payment	−6,813 sh	$1.96	−$13.4K	85,719
2020-02-28	LXRXLEXICON PHARMACEUTICALS, INC.M Exercise/Conversion	EVP and CMO	MExercise/Conversion	+4,228 sh	—	—	51,326
2020-02-28	LXRXLEXICON PHARMACEUTICALS, INC.M Exercise/Conversion	EVP and CMO	MExercise/Conversion	+2,585 sh	—	—	53,911
2020-02-28	LXRXLEXICON PHARMACEUTICALS, INC.M Exercise/Conversion	EVP and CMO	MExercise/Conversion	+8,570 sh	—	—	62,481
2020-02-28	LXRXLEXICON PHARMACEUTICALS, INC.M Exercise/Conversion	EVP and CMO	MExercise/Conversion	+23.5K sh	—	—	85,944
2020-02-28	LXRXLEXICON PHARMACEUTICALS, INC.F Tax Payment	EVP and CMO	FTax Payment	−13.3K sh	$2.77	−$36.9K	72,639
2020-02-28	LXRXLEXICON PHARMACEUTICALS, INC. · Restricted Stock UnitsM Exercise/Conversion	EVP and CMO	MExercise/Conversion	−4,228 sh	—	—	0
2020-02-28	LXRXLEXICON PHARMACEUTICALS, INC. · Restricted Stock UnitsM Exercise/Conversion	EVP and CMO	MExercise/Conversion	−2,585 sh	—	—	2,585
2020-02-28	LXRXLEXICON PHARMACEUTICALS, INC. · Restricted Stock UnitsM Exercise/Conversion	EVP and CMO	MExercise/Conversion	−8,570 sh	—	—	8,570
2020-02-28	LXRXLEXICON PHARMACEUTICALS, INC. · Restricted Stock UnitsM Exercise/Conversion	EVP and CMO	MExercise/Conversion	−23.5K sh	—	—	46,927
2020-02-06	LXRXLEXICON PHARMACEUTICALS, INC. · Restricted Stock UnitsA Award	EVP and CMO	AAward	+82.4K sh	—	—	82,410
2020-02-06	LXRXLEXICON PHARMACEUTICALS, INC. · Stock Option (Right to Buy)A Award	EVP and CMO	AAward	+247K sh	—	—	247,220
2019-02-28	LXRXLEXICON PHARMACEUTICALS, INC.M Exercise/Conversion	EVP and CMO	MExercise/Conversion	+4,550 sh	—	—	38,525
2019-02-28	LXRXLEXICON PHARMACEUTICALS, INC.M Exercise/Conversion	EVP and CMO	MExercise/Conversion	+4,227 sh	—	—	42,752
2019-02-28	LXRXLEXICON PHARMACEUTICALS, INC.M Exercise/Conversion	EVP and CMO	MExercise/Conversion	+2,585 sh	—	—	45,337
2019-02-28	LXRXLEXICON PHARMACEUTICALS, INC.M Exercise/Conversion	EVP and CMO	MExercise/Conversion	+8,570 sh	—	—	53,907
2019-02-28	LXRXLEXICON PHARMACEUTICALS, INC.F Tax Payment	EVP and CMO	FTax Payment	−6,809 sh	$5.51	−$37.5K	47,098
2019-02-28	LXRXLEXICON PHARMACEUTICALS, INC. · Restricted Stock UnitsM Exercise/Conversion	EVP and CMO	MExercise/Conversion	−4,550 sh	—	—	0
2019-02-28	LXRXLEXICON PHARMACEUTICALS, INC. · Restricted Stock UnitsM Exercise/Conversion	EVP and CMO	MExercise/Conversion	−4,227 sh	—	—	4,228
2019-02-28	LXRXLEXICON PHARMACEUTICALS, INC. · Restricted Stock UnitsM Exercise/Conversion	EVP and CMO	MExercise/Conversion	−2,585 sh	—	—	5,170
2019-02-28	LXRXLEXICON PHARMACEUTICALS, INC. · Restricted Stock UnitsM Exercise/Conversion	EVP and CMO	MExercise/Conversion	−8,570 sh	—	—	17,140
2019-02-07	LXRXLEXICON PHARMACEUTICALS, INC. · Stock Option (Right to Buy)A Award	EVP and CMO	AAward	+131K sh	—	—	130,710
2019-02-07	LXRXLEXICON PHARMACEUTICALS, INC. · Restricted Stock UnitsA Award	EVP and CMO	AAward	+70.4K sh	—	—	70,390
2018-02-28	LXRXLEXICON PHARMACEUTICALS, INC.M Exercise/Conversion	EVP and CMO	MExercise/Conversion	+2,821 sh	—	—	27,434
2018-02-28	LXRXLEXICON PHARMACEUTICALS, INC.M Exercise/Conversion	EVP and CMO	MExercise/Conversion	+4,550 sh	—	—	31,984
2018-02-28	LXRXLEXICON PHARMACEUTICALS, INC.M Exercise/Conversion	EVP and CMO	MExercise/Conversion	+4,228 sh	—	—	36,212
2018-02-28	LXRXLEXICON PHARMACEUTICALS, INC.M Exercise/Conversion	EVP and CMO	MExercise/Conversion	+2,585 sh	—	—	38,797
2018-02-28	LXRXLEXICON PHARMACEUTICALS, INC.F Tax Payment	EVP and CMO	FTax Payment	−4,822 sh	$8.53	−$41.1K	33,975
2018-02-28	LXRXLEXICON PHARMACEUTICALS, INC. · Restricted Stock UnitsM Exercise/Conversion	EVP and CMO	MExercise/Conversion	−2,821 sh	—	—	0
2018-02-28	LXRXLEXICON PHARMACEUTICALS, INC. · Restricted Stock UnitsM Exercise/Conversion	EVP and CMO	MExercise/Conversion	−4,550 sh	—	—	4,550
2018-02-28	LXRXLEXICON PHARMACEUTICALS, INC. · Restricted Stock UnitsM Exercise/Conversion	EVP and CMO	MExercise/Conversion	−4,228 sh	—	—	8,455
2018-02-28	LXRXLEXICON PHARMACEUTICALS, INC. · Restricted Stock UnitsM Exercise/Conversion	EVP and CMO	MExercise/Conversion	−2,585 sh	—	—	7,755
2018-02-08	LXRXLEXICON PHARMACEUTICALS, INC. · Restricted Stock UnitsA Award	EVP and CMO	AAward	+25.7K sh	—	—	25,710
2018-02-08	LXRXLEXICON PHARMACEUTICALS, INC. · Stock Option (Right to Buy)A Award	EVP and CMO	AAward	+72.3K sh	—	—	72,330
2017-02-28	LXRXLEXICON PHARMACEUTICALS, INC.M Exercise/Conversion	EVP and CMO	MExercise/Conversion	+2,500 sh	—	—	18,266
2017-02-28	LXRXLEXICON PHARMACEUTICALS, INC.M Exercise/Conversion	EVP and CMO	MExercise/Conversion	+2,822 sh	—	—	21,088
2017-02-28	LXRXLEXICON PHARMACEUTICALS, INC.M Exercise/Conversion	EVP and CMO	MExercise/Conversion	+4,550 sh	—	—	25,638
2017-02-28	LXRXLEXICON PHARMACEUTICALS, INC.M Exercise/Conversion	EVP and CMO	MExercise/Conversion	+4,227 sh	—	—	29,865
2017-02-28	LXRXLEXICON PHARMACEUTICALS, INC.F Tax Payment	EVP and CMO	FTax Payment	−5,252 sh	$16.45	−$86.4K	24,613
2017-02-28	LXRXLEXICON PHARMACEUTICALS, INC. · Restricted Stock Units (Phantom Stock)M Exercise/Conversion	EVP and CMO	MExercise/Conversion	−2,500 sh	—	—	0
2017-02-28	LXRXLEXICON PHARMACEUTICALS, INC. · Restricted Stock Units (Phantom Stock)M Exercise/Conversion	EVP and CMO	MExercise/Conversion	−2,822 sh	—	—	2,821
2017-02-28	LXRXLEXICON PHARMACEUTICALS, INC. · Restricted Stock Units (Phantom Stock)M Exercise/Conversion	EVP and CMO	MExercise/Conversion	−4,550 sh	—	—	9,100
2017-02-28	LXRXLEXICON PHARMACEUTICALS, INC. · Restricted Stock Units (Phantom Stock)M Exercise/Conversion	EVP and CMO	MExercise/Conversion	−4,227 sh	—	—	12,683
2017-02-09	LXRXLEXICON PHARMACEUTICALS, INC. · Stock Option (Right to Buy)A Award	EVP and CMO	AAward	+41.4K sh	—	—	41,370
2017-02-09	LXRXLEXICON PHARMACEUTICALS, INC. · Restricted Stock Units (Phantom Stock)A Award	EVP and CMO	AAward	+10.3K sh	—	—	10,340
2016-02-29	LXRXLEXICON PHARMACEUTICALS, INC.M Exercise/Conversion	EVP and CMO	MExercise/Conversion	+1,857 sh	—	—	10,252
2016-02-29	LXRXLEXICON PHARMACEUTICALS, INC.M Exercise/Conversion	EVP and CMO	MExercise/Conversion	+2,500 sh	—	—	12,752
2016-02-29	LXRXLEXICON PHARMACEUTICALS, INC.M Exercise/Conversion	EVP and CMO	MExercise/Conversion	+2,821 sh	—	—	15,573
2016-02-29	LXRXLEXICON PHARMACEUTICALS, INC.M Exercise/Conversion	EVP and CMO	MExercise/Conversion	+4,550 sh	—	—	20,123

Recent filings

Accepted (ET)
Apr 244
Lapuerta Pablo0001127602-20-014487
SEC(opens sec.gov)
Mar 34
Lapuerta Pablo0001127602-20-008962
SEC(opens sec.gov)
Feb 104
Lapuerta Pablo0001127602-20-004591
SEC(opens sec.gov)
Mar 14
Lapuerta Pablo0001127602-19-009261
SEC(opens sec.gov)

Companies

LEXICON PHARMACEUTICALS, INC.EVP and CMOLXRX

Address

8800 TECHNOLOGY FOREST PLACE

THE WOODLANDS, TX, 77381